Abstract
These findings suggest that dual-task (DT) gait performance is not indicative of cognitive impairment in Parkinson’s Disease (PD). DT effects on gait parameters were substantial in both cognitively impaired and unimpaired patients, potentially overlaying the effect of cognitive impairment on DT gait costs. Limits of the Montreal Cognitive Assessment (MoCA) in detecting motor-function specific cognitive performance or variable individual response to the DT as influencing factors cannot be excluded. Therefore, DT gait parameters as a marker for cognitive performance should be carefully interpreted in the clinical context.
Introduction
A common clinical assumption in Parkinson’s Disease (PD) management is that significant gait degradation during a simultaneous mental task—a "dual-task" (DT) paradigm—serves as a clear indicator of cognitive impairment. This theory posits that gait changes reflect a lack of cognitive "reserve." However, whether these changes can serve as a reliable biomarker for cognitive decline remains debated. This study evaluates whether spatiotemporal gait parameters under DT conditions accurately reflect cognitive status as measured by the Montreal Cognitive Assessment (MoCA).
Methods
The researchers conducted a retrospective analysis of 67 PD patients selected from a larger cohort at the Movement Disorders Outpatient Clinic, University Hospital Erlangen.
Patients were categorized into "cognitively impaired" (MoCA < 26) and "unimpaired" (MoCA ≥ 26) groups, matched for age, gender, and disease duration. Gait analysis was performed using SHIMMER 2 inertial sensors on the heels to measure 13 spatiotemporal parameters. The protocol included:
- Single Task (ST): Walking 20 meters at a self-chosen speed.
- Dual Task (DT): Walking while performing serial subtractions of 3 from a random number.
The primary metric was "DT cost," defined as the percentage change in gait performance from ST to DT.
Results
The study revealed that DT gait performance is a poor predictor of clinical cognitive scores.
The "Cognitive Tank" Paradox
Surprisingly, both groups were significantly challenged by the dual task. The "unimpaired" group actually showed slightly larger DT costs in velocity and stride time, possibly due to prioritizing the cognitive task over walking.
Weak Predictive Power
Linear regression showed that DT gait parameters (specifically stride length, swing time variability, and max toe clearance) explained only 8.6% of the variance in MoCA scores. Even when accounting for clinical confounders like age and disease duration, the model's explanatory power only reached approximately 30%.
Universal Interference
Gait degradation was universal; velocity dropped by 24% in the impaired group and 32% in the unimpaired group. The interference between motor and cognitive tasks appears to be a general feature of PD that manifests independently of the clinical threshold for cognitive impairment.
Discussion
The findings suggest that while DT gait analysis is valuable for assessing fall risk and general motor-cognitive interference, it should not be used as a standalone diagnostic tool for cognitive impairment.
Several factors may contribute to this lack of correlation. The MoCA is a global screening tool and may not capture the specific executive functions, such as set-shifting or divided attention, required for dual-tasking. Additionally, the lack of explicit instructions regarding task prioritization (e.g., "posture-first") may have introduced individual variability. Finally, the difference in difficulty between the MoCA's "serial 7" task and the study's "serial 3" task might have masked potential correlations.
Clinicians should interpret DT gait parameters carefully within the broader clinical context rather than as a direct proxy for cognitive status.
Summary updated